The success of short-course chemotherapy for tuberculosis, the similarity between
Mycobacterium tuberculosis and M. kansasii and the effectiveness of rifampin against the …

Forty patients with pulmonary disease caused by Mycobacterium kansasii were treated
initially with rifampin, isoniazid, and ethambutol daily for 12 months, and with streptomycin …

An evaluation of chemotherapy was made for 256 patients with pulmonary infection due to
Mycobacterium kansasii. Studies of in vitro resistance of M. kansasii and Mycobacterium …

Records of 244 patients with Mycobacterium kansasii isolated from their sputum were
reviewed. Of the 244 patients, 82 failed to meet study criteria and were excluded. Response …

Mycobacterium kansasii infection responds well to antituberculous drugs, and in the initial
phase of treatment, many patients with M. kansasii infection are regarded as tuberculosis …

We initiated a prospective trial of an intermittent clarithromycin-containing regimen for the
treatment of patients with Mycobacterium kansasii lung disease. Eighteen patients (10 men …

BACKGROUND: Patients with non-tuberculous mycobacteria are usually started on
conventional antituberculous triple therapy once acid fast bacilli are detected, before the …

Setting: Chest Clinic, Sant Pau Hospital, Barcelona, Spain. Objective: To assess the
therapeutic response of pulmonary disease due to Mycobacterium kansasii to 12 and 18 …

Background: The prevalence of tuberculosis in Korea decreased remarkably for the past 30
years, while for at least the recent 10 years, the frequency of disease attributable to …

Chemotherapy of pulmonary disease due to Mycobacterium kansasii has not always been
successful, and resectional surgery has been used frequently in the treatment of this …